Chlorthalidone NDC 62135-505

NDC codes

FDA NDC Directory

Product NDC (as listed)62135-505Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62135-0505Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62135-505-30	62135050530	30 TABLET in 1 BOTTLE (62135-505-30)Marketed from Feb 7, 2022
62135-505-90	62135050590	90 TABLET in 1 BOTTLE (62135-505-90)Marketed from Feb 7, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Chlorthalidone
Generic name (nonproprietary): chlorthalidone
Active ingredients: Chlorthalidone — 25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Chartwell RX, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211063
Marketing start: Feb 26, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Increased Diuresis (Physiologic effect)
Identifiers: Product ID 62135-505_459bb5c2-1a17-e530-e063-6294a90a8e0bSPL ID 459bb5c2-1a17-e530-e063-6294a90a8e0bSPL set ID 648f005f-1eae-4718-bc3a-2587d706fae2RxCUI 197499, 197500UNII Q0MQD1073QUPC 0362135505301, 0362135506308, 0362135506902, 0362135505905
Pharmacologic class: Thiazide-like Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462135050530 followed by a unit qualifier and the quantity

Package 62135-0505-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 10, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Diuretics such as chlorthalidone are indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effect of other antihypertensive drugs in the more severe forms of hypertension. Chlorthalidone is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Chlorthalidone has also been found useful in edema due to various forms of renal dysfunction, such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 211063

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211063
Product	Strength	Form · route	Labeler	Product NDC
Chlorthalidone	Chlorthalidone 50 mg/1	TabletOral	Chartwell RX, LLC	62135-506